🔎 Trials Near Me

Home › Non-Muscle Invasive Bladder Cancer › California

Pag-aaral pangklinika para sa Non-Muscle Invasive Bladder Cancer sa California

15 pag-aaral para sa Non-Muscle Invasive Bladder Cancer ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

  • University of California San Francisco, San Francisco
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06503614

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
  • USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
  • Genesis Healthcare-Torrance ( Site 0140), Torrance
  • at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

  • Tri Valley Urology - Murrieta, Murrieta
  • Eisenhower Medical Associates, Rancho Mirage
  • Om Research LLC, San Diego
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

  • UCLA, Los Angeles
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06919965

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07309445

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  • Michael G Oefelein Clinical Trials ( Site 0053), Bakersfield
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06637423

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Michael Oefelein Clinical Trials, Bakersfield
  • University of California Irvine Medical Center, Orange
  • Genesis Research LLC, Torrance
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • Michael Oefelein Clinical Trials, Bakersfield
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
  • University of California - Irvine, Orange
  • at 2 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • University of California - Irvine Medical Center, Irvine
  • UC San Diego Moores Cancer Center, La Jolla
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • at 2 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  • Unio Specialty Care - A Genesis Healthcare Partners Facility, Bakersfield
  • Genesis Research, Downey
  • Urology Center of Southern California, Murrieta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05710848

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

  • Golden State Urology, Sacramento
Nagre-recruitPhase 1/2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06800963

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

  • University of California Davis Comprehensive Cancer Center, Sacramento
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06173349

Blue Light Cystoscopy With Cysview® Registry

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California Los Angeles, Los Angeles
  • VA Palo Alto Health Care System, Palo Alto
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT02660645

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.